KATIE WINFREY: Open Payments
NPI 1679031488 · OXFORD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,649 in 105 payments from 17 companies in 2025. Trend: 2023 $1,625 · 2024 $1,864 · 2025 $1,649
Food & beverage: $1,588Education: $61
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $449 |
| Novartis Pharmaceuticals Corporation | 17 | $288 |
| PFIZER INC. | 22 | $164 |
| Arcutis Biotherapeutics, Inc. | 10 | $136 |
| Janssen Biotech, Inc. | 5 | $109 |
| Galderma Laboratories, L.P. | 4 | $74 |
| Lilly USA, LLC | 3 | $67 |
| Amgen Inc. | 3 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $61 |
| LEO Pharma Inc. | 2 | $51 |
Products named: SKYRIZI, COSENTYX, CIBINQO, Zoryve, RINVOQ, TREMFYA, EBGLYSS, OTEZLA.
Industry payments across AL — which companies pay providers there.
